Identification of cell-specific soluble mediators and cellular targets during cell therapy for the treatment of heart failure

Regenerative Medicine

Volumn 3, Issue 6, 2008, Pages 953-962

  Lee, Joon ^a   Stagg, Mark A ^a   Siedlecka, Urszula ^a   Latif, Najma ^a   Soppa, Gopal K R ^a   Yacoub, Magdi ^a   Terracciano, Cesare M N ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Adult progenitor cells; Calcium cycling; Cell therapy; Excitation contraction coupling; Heart failure; Paracrine hypothesis

Indexed keywords

CALCIUM ION; CYTOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL FUNCTION; CELL SECRETION; CELL SPECIFICITY; CELL THERAPY; COCULTURE; CONTROLLED STUDY; DIASTOLE; FEMALE; HEART CONTRACTION; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE CELL; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; SYSTOLE; TARGET CELL;

ADULT STEM CELLS; ANIMALS; CALCIUM; COCULTURE TECHNIQUES; FEMALE; HEART FAILURE; HUMANS; MYOCYTES, CARDIAC; ORGAN SPECIFICITY; PARACRINE COMMUNICATION; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; TISSUE THERAPY;

EID: 58149122758     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460751.3.6.953     Document Type: Article

References (47)

1. Rosenzweig A: Cardiac cell therapy: mixed results from mixed cells. N. Engl. J. Med. 355(12), 1274-1277 (2006).
2. Nadal-Ginard B, Fusier V: Myocardial cell therapy at the crossroads. Nat. Clin. Pract. Cardiovasc. Med. 4(1), 1 (2007).
3. Jessup M, Brozena S: Heart failure. N. Engl. J. Med. 348(20), 2007-2018 (2003).
4. Abdel-Latif A, Bolli R, Tleyjeh IM et al.: Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch. Intern. Med. 167(10), 989-997 (2007).
5. Assmus B, Honold J, Schachinger V et al.: Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 355(12), 1222-1232 (2006).
6. Hagege AA, Marolleau JP, Vilquin JT et al.: Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of tht first Phase I cohort of patients. Circulation 114(Suppl. 1), I108-I113 (2006).
7. Meyer GP, Wollert KC, Lotz J et al.: Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (bone marrow transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113(10), 1287-1294 (2006).
8. Murry CE, Field LJ, Menasche P: Cell-based cardiac repair: reflections at the 10-year point. Circulation 112(20), 3174-3183 (2005).
9. Dai W, Hale SL, Martin BJ et al.: Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112(2), 214-223 (2005).
10. Dowell JD, Rubart M, Pasumarthi KB, Soonpaa MH, Field LJ: Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc. Res. 58(2), 336-350 (2003).
11. Jackson KA, Majka SM, Wang H et al.: Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107(11), 1395-1402 (2001).
12. Taylor DA, Atkins BZ, Hungspreugs P et al.: Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med. 4(8), 929-933 (1998).
13. Schachinger V, Erbs S, Elsasser A et al.: Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355(12), 1210-1221 (2006).
14. Orlic D, Kajstura J, Chimenti S et al.: Bone marrow cells regenerate infarcted myocardium. Nature 410 (6829), 701-705 (2001).
15. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC: Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428(6983), 668-673 (2004).
16. Murry CE, Soonpaa MH, Reinecke H et al.: Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428(6983), 664-668 (2004).
17. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, Charpak S: Myoblasts transplanted into rat infarcted myocardium, are functionally isolated from their host. Proc. Natl Acad. Sci. USA 100(13), 7808-7811 (2003).
18. Laflamme MA, Zbinden S, Epstein SE, Murry CE: Cell-based therapy for myocardial iaschemia and infarction: pathophysiological mechanisms. Annu. Rev. Pathol. 2, 307-339 (2007).
19. Dimmeler S, Zeiher AM, Schneider MD: Unchain my heart: the scientific foundations of cardiac repair. J. Clin. Invest. 115(3), 572-583 (2005).
20. Gnecchi M, He H, Noiseux N et al.: Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 20(6), 661-669 (2006).
21. Kinnaird T, Stabile E, Burnett MS et al.: Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109(12), 1543-1549 (2004).
22. Uemura R, Xu M, Ahmad N, Ashraf M: Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res. 98(11), 1414-1421 (2006).
23. Xu M, Uemura R, Dai Y, Wang Y, Pasha Z, Ashraf M: In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J. Mol. Cell Cardiol. 42(2), 441-448 (2007).
24. Tateno K, Minamino T, Toko H et al.: Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ. Res. 98(9), 1194-1202 (2006).
25. Cho HJ, Lee N, Lee JY et al.: Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J. Exp. Med. 204(13), 3257-3269 (2007).
26. Rosenblatt JD, Lunt AI, Parry DJ, Partridge TA: Culturing satellite cells from living single muscle fiber explants. In Vitro Cell. Dev. Biol. Anim. 31(10), 773-779 (1995).
27. Sanchez A, Fernandez ME, Rodriguez A et al.: Experimental models for cardiac regeneration. Nat. Clin. Pract. Cardiovasc. Med. 3(Suppl. 1), S29-S32 (2006).
28. Pfeffer MA: Left ventricular remodeling after acute myocardial infarction. Annu. Rev. Med. 46, 455-466 (1995).
29. Hudlicka O, Brown M, Egginton S: Angiogenesis in skeletal and cardiac muscle. Physiol. Rev. 72(2), 369-417 (1992).
30. Jugdutt BI: Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 108(11), 1395-1403 (2003).
31. Hasenfuss G, Pieske B: Calcium cycling in congestive heart failure. J. Mol. Cell Cardiol. 34(8), 951-969 (2002).
32. 2+-ATPase in a rat model of heart failure. Circulation 104(12), 1424-1429 (2001).
33. Huang F, Shan J, Reiken S, Wehrens XH, Marks AR: Analysis of calstabin 2 (FKBP12.6)-ryanodine receptor interactions: rescue of heart failure by calstabin 2 in mice. Proc. Natl Acad. Sci. USA 103(9), 3456-3461 (2006).
34. Lee J, Stagg MA, Soppa GK, Siedlecka U, Yacoub MH, Terracciano CM: Skeletal myoblasts and bone marrow-derived cells enhance the contractile function of isolated failing cardiomyocytes in co-culture. Circulation 114(Suppl. S18 II), 93-93 (2006).
35. Soppa GK, Lee J, Stagg MA et al.: Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure. Cardiovasc. Res. 77(4), 695-706 (2008).
36. 2+-dependent positive inotropic effects in failing human myocardium. Circ. Res. 92(2), 169-176 (2003).
37. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross J Jr: Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J. Clin. Invest. 95(2), 619-627 (1995).
38. Freestone NS, Ribaric S, Mason WT: The effect of insulin-like growth factor-1 on adult rat cardiac contractility. Mol. Cell. Biochem. 163-164, 223-229 (1996).
39. Li Q, Li B, Wang X et al.: Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J. Clin. Invest. 100(8), 1991-1999 (1997).
40. Ferrara N: Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am. J. Physiol. Cell. Physiol. 280(6), C1358-C1366 (2001).
41. Seko Y, Seko Y, Takahashi N, Shibuya M, Yazaki Y: Pulsatile stretch stimulates vascular endothelial growth factor (VEGF) secretion by cultured rat cardiac myocytes. Biochem. Biophys. Res. Commun. 254(2), 462-465 (1999).
42. Rottbauer W, Just S, Wessels G et al.: VEGF-PLCg1 pathway controls cardiac contractility in the embryonic heart. Genes Dev. 19(13), 1624-1634 (2005).
43. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett. 298(1), 29-32 (1992).
44. Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman MI, Leonard EJ: Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 244(2), 487-493 (1989).
45. Frangogiannis NG, Dewald O, Xia Y et al.: Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation 115(5), 584-592 (2007).
46. Kolattukudy PE, Quach T, Bergese S et al.: Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle. Am. J. Pathol. 152(1), 101-111 (1998).
47. Zhou L, Azfer A, Niu J et al.: Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction. Circ. Res. 98(9), 1177-1185 (2006).